Showing 3 results for:
Sickle Cell
Popular topics
All results
The sickle cell disease has plagued Black people for decades. However, with a new advancement in technology, people living with the disease have been given another chance. Take Jimi Olaghere, for example, who has lived with sickle cell for his entire life, but thanks to a new clinical trial, things are looking up, per reports from BBC. After reading an article about a new clinical trial using gene editing to help treat those living with sickle cell, Jimi Olaghere immediately contacted the medical team in charge. After just a month, he and his wife Amanda took a trek to Nashville, Tennessee’s Sarah Cannon Research Institute to see if he qualified. He recalls learning the news that he did indeed qualify and called it “the best Christmas present ever.” As someone who’s lived with the disease since his childhood, Olaghere has had to face the challenges that come with sickle cell for his entire life. “You always have to be in a war mindset, knowing that your days are going to be filled...
Sickle cell anemia is an inherited red blood cell disorder in which there aren’t enough healthy red blood cells to carry oxygen through your body. A person inflicted with the disease has red blood cells that are shaped like sickles, instead of the round shape that healthy cells have. Treatment options are different for anyone living with sickle cell, and for many patients, there is no viable cure. African Americans are at a relatively high risk of having the disease, with 1 in 13 babies being born with sickle cell. We sat down with a streamer named Ryan who is using his passion for gaming to help raise money to advocate for people affected by sickle cell conditions! Streamer Beginnings Two Average Gamers: How’d you get into streaming? Ryan: I was introduced to it by a friend. After watching her stream, it looked really cool and she recommended that I try it out. I started out really simple with the Twitch app on my Xbox One and have continued to improve my setup since then. TAG: Why...